The purpose of this study is to test the safety, activity and best doses of FOLFOX-A which
consists of the standard chemotherapy drugs fluorouracil, leucovorin, oxaliplatin and
abraxane. Each of these drugs are currently used in pancreatic cancer.
The experimental part of the study is combining these drugs together in FOLFOX-A.